Join us for a timely discussion on screening and early intervention of MASH, a silent but progressive liver disease. Dr. Arun Sanyal and Dr. Mary Rinella highlight the critical role of primary care physicians in early detection, risk assessment using noninvasive tests, and timely referral empowering clinicians to intervene before cirrhosis develops.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
56 of 56 courses listed here are free.
Collected from the provider’s public pages
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Board review / self-assessment
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedNov 21, 2025
-
Last day to claim creditNov 22, 2026 6 weeks left
-
American Association for the Study of Liver Diseases Unmasking MASH and MASLD
-
Catalyst Medical Education, LLC +1 A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration
-
Learner’s Digest International (TM) MASH and PCOS/Metabolic Associated Steatotic Liver Disease
